Indefinite-Lived Research and Development Assets
Philip Morris International Indefinite-Lived Research and Development Assets decreased by 1.4% to $4.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.2%, from $4.56B to $4.71B. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Research and Development Assets shows an upward trend with a 29.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
Detailed definition
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Peer comparison
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.26B | $1.30B | $1.31B | $1.32B | $1.29B | $1.27B | $3.35B | $3.41B | $3.42B | $4.42B | $4.54B | $4.39B | $4.54B | $4.63B | $4.45B | $4.56B | $4.72B | $4.73B | $4.78B | $4.71B |
| QoQ Change | — | +2.7% | +1.3% | +0.7% | -2.4% | -1.7% | +164.1% | +1.8% | +0.4% | +29.2% | +2.9% | -3.3% | +3.4% | +2.0% | -4.0% | +2.6% | +3.5% | +0.1% | +1.0% | -1.4% |
| YoY Change | — | — | — | — | +2.2% | -2.2% | +155.0% | +157.8% | +165.2% | +248.5% | +35.8% | +29.0% | +32.9% | +4.8% | -2.1% | +3.9% | +4.0% | +2.1% | +7.4% | +3.2% |
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Philip Morris International's indefinite-lived research and development assets?
- Philip Morris International (PM) reported indefinite-lived research and development assets of $4.71B in Q1 2026.
- How has Philip Morris International's indefinite-lived research and development assets changed year-over-year?
- Philip Morris International's indefinite-lived research and development assets increased by 3.2% year-over-year, from $4.56B to $4.71B.
- What is the long-term trend for Philip Morris International's indefinite-lived research and development assets?
- Over 5 years (2020 to 2025), Philip Morris International's indefinite-lived research and development assets has grown at a 29.9% compound annual growth rate (CAGR), from $1.29B to $4.78B.
- What does indefinite-lived research and development assets mean?
- The value of ongoing research projects acquired from other companies that are not yet ready for sale.